Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2025-12-24 @ 9:11 PM
NCT ID: NCT07116304
Eligibility Criteria: Inclusion Criteria: * Adult patients, ≥18 years * ASA grading I-II * Patients undergoing elective surgical procedures across all surgical specialties. * Can speak Arabic or English Exclusion Criteria: * Difficulty in communicating. * Liver Cirrhosis patients * Renal failure or creatinine clearance (CrCl) ≤ 10umol/L, * Known Lidocaine, parecoxib and/or propofol allergy. * patients who are not using propofol for an induction. * Any known contraindication to propofol, parecoxib or lidocaine. (this will include renal failure or cirrhosis of the liver as noted above) * Patients refusing to be involved in the study. * ASA(American society of anaesthesia) grading 3-6. * Any patient that IV access cannot be established in the dorsum of the hand. * Pregnant women. * Patients with chronic pain disorders. * Patients who received any form of analgesia within the last hour.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT07116304
Study Brief:
Protocol Section: NCT07116304